Statistical decisions and the interim analyses of clinical trials
- 142 Downloads
This paper analyzes statistical decisions during the interim analyses of clinical trials. After some general remarks about the ethical and scientific demands of clinical trials, I introduce the notion of a hard-case clinical trial, explain the basic idea behind it, and provide a real example involving the interim analyses of zidovudine in asymptomatic HIV-infected patients. The example leads me to propose a decision analytic framework for handling ethical conflicts that might arise during the monitoring of hard-case clinical trials. I use computer simulations to show how the framework can assist in reconciling certain ethical conflicts. The framework is partial, lacking the precision of a complete systematization of statistical monitoring procedures in practice.
KeywordsEvidence Statistical inference Confirmation Bayesian Case study HIV/AIDS
- 1.Idänpään-Heikkilä, J., and Sev Fluss. 2005. Emerging international norms for clinical testing. In Ethics and the pharmaceutical industry, ed. M.A. Santoro and T.M. Gorrie, 37–47. Cambridge: Cambridge University Press.Google Scholar
- 2.Epstein, S. 1996. Impure science–AIDS, activism, and the politics of knowledge. Berkeley, CA: University of California Press.Google Scholar
- 3.Petryna, A. 2009. When experiments travel. Princeton, NJ: Princeton University Press.Google Scholar
- 4.Hawkins, J.S., and E.J. Emanuel, eds. 2008. Exploitation and developing countries: The ethics of clinical research. Princeton, NJ: Princeton University Press.Google Scholar